The diagnosis and management of thyroid nodules: a review

C Durante, G Grani, L Lamartina, S Filetti, SJ Mandel… - Jama, 2018 - jamanetwork.com
Importance Thyroid nodules are common, being detected in up to 65% of the general
population. This is likely due to the increased use of diagnostic imaging for purposes …

[HTML][HTML] Understanding the ever-changing incidence of thyroid cancer

CM Kitahara, JA Sosa - Nature Reviews Endocrinology, 2020 - nature.com
This Comment article provides a behind-the-scenes perspective and update of our 2016
Review, which discussed possible factors contributing to thyroid cancer incidence trends …

Performance of a multigene genomic classifier in thyroid nodules with indeterminate cytology: a prospective blinded multicenter study

DL Steward, SE Carty, RS Sippel, SP Yang… - JAMA …, 2019 - jamanetwork.com
Importance Approximately 20% of fine-needle aspirations (FNA) of thyroid nodules have
indeterminate cytology, most frequently Bethesda category III or IV. Diagnostic surgeries can …

Effectiveness of molecular testing techniques for diagnosis of indeterminate thyroid nodules: a randomized clinical trial

MJ Livhits, CY Zhu, EJ Kuo, DT Nguyen, J Kim… - JAMA …, 2021 - jamanetwork.com
Importance Approximately 20% of thyroid nodules display indeterminate cytology. Molecular
testing can refine the risk of malignancy and reduce the need for diagnostic …

Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995–2015)

CM Kitahara, RM Pfeiffer, JA Sosa… - JNCI: Journal of the …, 2020 - academic.oup.com
Background Since the early 1980s, papillary thyroid cancer (PTC) incidence rates and the
prevalence of obesity, a risk factor for PTC, have increased substantially in the United …

Thyroid nodules: diagnostic evaluation based on thyroid cancer risk assessment

NS Ospina, NM Iñiguez-Ariza, MR Castro - bmj, 2020 - bmj.com
Thyroid nodules are extremely common and can be detected by sensitive imaging in more
than 60% of the general population. They are often identified in patients without symptoms …

Clinical safety of renaming encapsulated follicular variant of papillary thyroid carcinoma: is NIFTP truly benign?

DN Parente, WP Kluijfhout, PJ Bongers… - World Journal of …, 2018 - Wiley Online Library
Background Renaming encapsulated follicular variant of papillary thyroid carcinoma
(EFVPTC) to noninvasive follicular thyroid neoplasm with papillary‐like nuclear features …

Afirma gene sequencing classifier compared with gene expression classifier in indeterminate thyroid nodules

M Endo, F Nabhan, K Porter, K Roll, LA Shirley… - Thyroid, 2019 - liebertpub.com
Background: The Afirma Gene Expression Classifier (GEC) has been used to further
characterize cytologically indeterminate (cyto-I) thyroid nodules into either benign or …

[HTML][HTML] Targeted radionuclide therapy for patients with metastatic pheochromocytoma and paraganglioma: from low-specific-activity to high-specific-activity iodine …

C Jimenez, W Erwin, B Chasen - Cancers, 2019 - mdpi.com
Low-specific-activity iodine-131–radiolabeled metaiodobenzylguanidine (I-131-MIBG) was
introduced last century as a potential systemic therapy for patients with malignant …

Differential MicroRNA‐Signatures in Thyroid Cancer Subtypes

K Santiago, Y Chen Wongworawat… - Journal of Oncology, 2020 - Wiley Online Library
Thyroid cancer is one of the most common endocrine cancers, with an increasing trend in
the last few decades. Although papillary thyroid cancer is the most frequent subtype …